Tag: VYRSA V1

VYRSA Technologies announces worldwide launch of VYRSA V1 SI fusion system

VYRSA Technologies has announced US Food and Drug Administration (FDA) clearance of its VYRSA V1 sacroiliac (SI) fusion system. According to a press release, after...
Spinal News International

Write to us
Editor: Anthony Strzalek [email protected]
Advertising: Michael Broughton [email protected]


United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy